We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Deucravacitinib

Deucravacitinib | CAS NO:1609392-27-9 Deucravacitinib is used to treat moderate to severe plaque psoriasis, which is a skin disease with red patches and white scales that do not go away. It is given to patients who may receive other types of treatment, including pills, injection, or phototherapy (light treatment).Deucravacitinib is a breakthrough in the targeted treatment of moderate-to-severe plaque psoriasis.

We are the Synchemia Research Chemical specializes in manufacturing and supplying of Deucravacitinib  impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities. Deucravacitinib is used to treat the symptoms of migraine headaches (severe throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light). Deucravacitinib is in a class of medications called selective serotonin receptor agonists.. Buy Reliable and High-Purity Deucravacitinib Impurities, Delivered by Synchemia Research Chemicals.

download image Download catalogue

Pharmaceutical Reference Standards

Deucravacitinib Impurity 33
Deucravacitinib Impurity 33
CAT No SRC-D3513
CAS No 3030727-45-5
Mol.F. C11H14N4O
Mol.Wt. 218.3 g/mole
INV STATUS CUSTOM SYNTHESIS
Deucravacitinib Impurity 34
Deucravacitinib Impurity 34
CAT No SRC-D3514
CAS No 3030727-46-6
Mol.F. C21H24N8O2
Mol.Wt. 420.5 g/mole
INV STATUS CUSTOM SYNTHESIS
Deucravacitinib Impurity 35
Deucravacitinib Impurity 35
CAT No SRC-D3515
CAS No 874472-98-7
Mol.F. C8H6BrNO
Mol.Wt. 212.0 g/mole
INV STATUS CUSTOM SYNTHESIS
Deucravacitinib Impurity 36
Deucravacitinib Impurity 36
CAT No SRC-D3516
CAS No 758-17-8
Mol.F. C2H6N2O
Mol.Wt. 74.1 g/mole
INV STATUS UNDER SYNTHESIS
Deucravacitinib Impurity 37
Deucravacitinib Impurity 37
CAT No SRC-D3517
CAS No 2366234-17-3
Mol.F. C11H13N3O4
Mol.Wt. 251.2 g/mole
INV STATUS CUSTOM SYNTHESIS
Deucravacitinib Impurity 38
Deucravacitinib Impurity 38
CAT No SRC-D3518
CAS No 372118-00-8
Mol.F. C6H6N2O4
Mol.Wt. 170.1 g/mole
INV STATUS CUSTOM SYNTHESIS
Deucravacitinib Impurity 39
Deucravacitinib Impurity 39
CAT No SRC-D3519
CAS No 372118-01-9
Mol.F. C6H4Cl2N2O2
Mol.Wt. 207.0 g/mole
INV STATUS CUSTOM SYNTHESIS
Deucravacitinib Impurity 40
Deucravacitinib Impurity 40
CAT No SRC-D3520
CAS No 2417138-54-4
Mol.F. C9H8N4O3
Mol.Wt. 220.2 g/mole
INV STATUS CUSTOM SYNTHESIS
Deucravacitinib Impurity 41
Deucravacitinib Impurity 41
CAT No SRC-D3521
CAS No 1609394-09-3
Mol.F. C10H10N4O3
Mol.Wt. 234.2 g/mole
INV STATUS CUSTOM SYNTHESIS
Deucravacitinib Desmethyl Impurity
Deucravacitinib Desmethyl Impurity
CAT No SRC-D3522
CAS No NA
Mol.F. C19H17D3N8O3
Mol.Wt. 411.4 g/mole
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.